These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31281680)

  • 1. Noncompaction and Takotsubo Syndrome in a Neuromuscular Disorder.
    Finsterer J; Stöllberger C; Winkler WB
    Case Rep Cardiol; 2019; 2019():6902751. PubMed ID: 31281680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between takotsubo syndrome, left ventricular hypertrabeculation/noncompaction, neurologic and neuromuscular disorders.
    Stöllberger C; Finsterer J
    Rev Cardiovasc Med; 2021 Dec; 22(4):1413-1420. PubMed ID: 34957781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unclassified cardiomyopathies in neuromuscular disorders.
    Finsterer J; Stöllberger C
    Wien Med Wochenschr; 2013 Nov; 163(21-22):505-13. PubMed ID: 24154801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular implications in left ventricular hypertrabeculation/noncompaction.
    Finsterer J; Stöllberger C; Blazek G
    Int J Cardiol; 2006 Jun; 110(3):288-300. PubMed ID: 16364474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Neuromuscular Co-morbidity, Left Bundle Branch Block, and Atrial Fibrillation to Predict the Long-Term Prognosis of Left Ventricular Hypertrabeculation/Noncompaction.
    Stöllberger C; Hasun M; Winkler-Dworak M; Finsterer J
    Am J Cardiol; 2020 Aug; 128():168-173. PubMed ID: 32650915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiologic and neuromuscular co-morbidity influences mortality of patients with left ventricular hypertrabeculation/noncompaction: comparison with the Austrian general population.
    Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
    Acta Cardiol; 2007 Feb; 62(1):1-5. PubMed ID: 17375885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrabeculation/noncompaction with and without neuromuscular disorders.
    Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
    Int J Cardiol; 2004 Oct; 97(1):89-92. PubMed ID: 15336813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of electrocardiographic abnormalities with cardiac findings and neuromuscular disorders in left ventricular hypertrabeculation/non-compaction.
    Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
    Cardiology; 2007; 107(4):374-9. PubMed ID: 17284898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of CK-elevation in noncompaction with regard to cardiac and neuromuscular disease.
    Finsterer J; Stöllberger C; Krugluger W
    Int J Cardiol; 2008 Nov; 130(2):174-9. PubMed ID: 18055044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing left ventricular noncompaction by echocardiography and cardiac magnetic resonance imaging and its dependency on neuromuscular disorders.
    Stöllberger C; Kopsa W; Tscherney R; Finsterer J
    Clin Cardiol; 2008 Aug; 31(8):383-7. PubMed ID: 18727062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular disorders in left ventricular hypertrabeculation/noncompaction.
    Finsterer J; Stöllberger C; Fazio G
    Curr Pharm Des; 2010; 16(26):2895-904. PubMed ID: 20632953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological comorbidity affects prognosis in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Blazek G; Wegner C; Finsterer J
    Heart Lung; 2012; 41(6):594-8. PubMed ID: 22515930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of electrocardiographic abnormalities in association with neuromuscular disorders and survival in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Gerger D; Jirak P; Wegner C; Finsterer J
    Ann Noninvasive Electrocardiol; 2014 Nov; 19(6):567-73. PubMed ID: 24934299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular comorbidity, heart failure, and atrial fibrillation as prognostic factors in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Blazek G; Gessner M; Bichler K; Wegner C; Finsterer J
    Herz; 2015 Sep; 40(6):906-11. PubMed ID: 25939437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding left ventricular hypertrabeculation/noncompaction: pathomorphologic findings and prognostic impact of neuromuscular comorbidities.
    Stöllberger C; Finsterer J
    Expert Rev Cardiovasc Ther; 2019 Feb; 17(2):95-109. PubMed ID: 30570401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familal left ventricular hypertrabeculation (noncompaction) is myopathic.
    Finsterer J; Stöllberger C; Blazek G; Sehnal E
    Int J Cardiol; 2013 Apr; 164(3):312-7. PubMed ID: 21788087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac and neuromuscular implications of left bundle branch block in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J
    Can J Cardiol; 2009 Mar; 25(3):e82-5. PubMed ID: 19279992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive troponin-T in noncompaction is associated with neuromuscular disorders and poor outcome.
    Finsterer J; Stöllberger C; Krugluger W
    Clin Res Cardiol; 2007 Feb; 96(2):109-13. PubMed ID: 17146603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication.
    Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
    Int J Cardiol; 2007 Jun; 119(1):28-32. PubMed ID: 17023079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation in left ventricular noncompaction with and without neuromuscular disorders is associated with a poor prognosis.
    Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J
    Int J Cardiol; 2009 Mar; 133(1):41-5. PubMed ID: 18255171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.